Professional
Added to YB: 2024-10-29
Pitch date: 2024-10-22
PFE [bullish]
Pfizer Inc.
-0.3%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$147.0B
Pitch Price
$26.51
Price Target
N/A
Dividend
6.65%
EV/EBITDA
7.58
P/E
15.02
EV/Sales
3.09
Sector
Pharmaceuticals
Category
value
Show full summary:
Starboard Value 2024 Active-Passive Investor Summit - Pfizer Inc.
PFE: Undervalued at 6.3x P/E vs peers' 14x. Poor innovation track record, weak pipeline, questionable M&A, and forecasting issues led to valuation discount. Needs to improve R&D returns from 15% to peer median 38%. Board must hold management accountable to drive $79B 2030 sales and >$4.25 EPS.
Read full article (20 min)